Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

John Seetoo | Feb 11, 2026 at 7:15 AM EST

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

One of the biggest trends in the fight against obesity has been the explosion in popularity of GLP-1 medications. Created…

Rich Duprey | Feb 4, 2026 at 2:39 PM EST

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

The rivalry in the GLP-1 market between pharmaceutical leaders Eli Lilly (NYSE:LLY | LLY Price Prediction) and Novo Nordisk (NYSE:NVO)…

Joel South | Feb 2, 2026 at 11:40 AM EST

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open. Wall Street expects earnings of…

Michael Williams | Jan 23, 2026 at 2:06 PM EST

Investor Bets $100k On David v Goliath Matchup With Altimmune and Eli Lilly

Shares of Altimmune (NASDAQ:ALT) surged 35.4% over the past week, coinciding with a dramatic shift in retail investor sentiment on…

Austin Smith | Jan 23, 2026 at 10:36 AM EST

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss drug revolution.…

Joey Frenette | Jan 22, 2026 at 1:17 PM EST

Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7

It feels like a great rotation out of the Magnificent Seven has already kicked off just over a quarter ago.…

Trey Thoelcke | Jan 19, 2026 at 8:45 AM EST

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

Alumis, Aktis Oncology, and W.R. Berkley saw the most prominent insider buying of the past week. There were a handful…

Rich Duprey | Jan 12, 2026 at 12:48 PM EST

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process…

William Temple | Jan 10, 2026 at 8:59 AM EST

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but…

Rich Duprey | Dec 28, 2025 at 7:29 AM EST

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026

Dividend growth investing builds long-term wealth for retirement by focusing on companies that consistently increase payouts. These stocks provide rising…

Rich Duprey | Dec 19, 2025 at 10:52 AM EST

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Eli Lilly (NYSE:LLY | LLY Price Prediction) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss.…

Omor Ibne Ehsan | Dec 17, 2025 at 10:05 AM EST

Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly

Very few investors can match Stanley Druckenmiller. He delivered an average annual return of over 30% over three decades at…

Lee Jackson | Dec 16, 2025 at 8:09 AM EST

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Pre-Market Stock Futures: The futures are trading lower after what started as a bounce-back Monday turned into a reversal Monday,…

Ian Cooper | Dec 11, 2025 at 10:44 AM EST

Stock Market Live December 11, 2025: S&P 500 (SPY) in the Red After Nearing Record Highs

Just yesterday, markets celebrated the latest quarter-point cut from the Federal Reserve, which lowered rates to a range of 3.5%…

William Temple | Dec 8, 2025 at 8:21 AM EST

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two…

1 2 3 4 5 … 42

Eli Lilly : LLY

All Eli Lilly Articles

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Investor Bets $100k On David v Goliath Matchup With Altimmune and Eli Lilly

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Stock Market Live December 11, 2025: S&P 500 (SPY) in the Red After Nearing Record Highs

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Eli Lilly : LLY

All Eli Lilly Articles

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Investor Bets $100k On David v Goliath Matchup With Altimmune and Eli Lilly

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Stock Market Live December 11, 2025: S&P 500 (SPY) in the Red After Nearing Record Highs

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026